These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36375661)

  • 1. Pancreastatin inhibitor PSTi8 balances energy homeostasis by attenuating adipose tissue inflammation in high fat diet fed mice.
    Goand UK; Verma S; Gupta AP; Garg R; Dadge S; Gayen JR
    Peptides; 2023 Jan; 159():170902. PubMed ID: 36375661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-metabolic effect of pancreastatin inhibitor PSTi8 in diet induced obese mice: In vitro and in vivo findings.
    Goand UK; Verma S; Patel I; Tasneem S; Garg R; Gayen JR
    Life Sci; 2023 Mar; 316():121415. PubMed ID: 36690247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice.
    Gupta AP; Garg R; Singh P; Goand UK; Syed AA; Valicherla GR; Riyazuddin M; Mugale MN; Gayen JR
    Eur J Pharmacol; 2020 Aug; 881():173204. PubMed ID: 32439261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
    Gupta AP; Syed AA; Garg R; Goand UK; Singh P; Riyazuddin M; Valicherla GR; Husain A; Gayen JR
    Eur J Pharmacol; 2019 Dec; 864():172723. PubMed ID: 31586632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.
    Bandyopadhyay GK; Lu M; Avolio E; Siddiqui JA; Gayen JR; Wollam J; Vu CU; Chi NW; O'Connor DT; Mahata SK
    Diabetes; 2015 Jan; 64(1):104-16. PubMed ID: 25048197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue.
    Kumar D; Goand UK; Gupta S; Shankar K; Varshney S; Rajan S; Srivastava A; Gupta A; Vishwakarma AL; Srivastava AK; Gaikwad AN
    Eur J Pharmacol; 2018 Mar; 822():32-42. PubMed ID: 29331565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreastatin mediated regulation of UCP-1 and energy expenditure in high fructose fed perimenopausal rats.
    Singh P; Reza MI; Syed AA; Husain A; Katekar R; Gayen JR
    Life Sci; 2021 Aug; 279():119677. PubMed ID: 34081990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreastatin inhibitor PSTi8 ameliorates insulin resistance by decreasing fat accumulation and oxidative stress in high-fat diet-fed mice.
    Garg R; Agarwal A; Katekar R; Goand UK; Singh N; Yadav S; Rathaur S; Verma S; Maity D; Vishwakarma S; Gayen JR
    Amino Acids; 2023 Nov; 55(11):1587-1600. PubMed ID: 37716928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.
    Hossain Z; Valicherla GR; Gupta AP; Syed AA; Riyazuddin M; Chandra S; Siddiqi MI; Gayen JR
    Sci Rep; 2018 Jun; 8(1):8715. PubMed ID: 29880906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning.
    Reza MI; Syed AA; Singh P; Husain A; Gayen JR
    Life Sci; 2021 Nov; 284():119905. PubMed ID: 34453940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brown adipose tissue in modulating adipose tissue inflammation and insulin resistance in high-fat diet fed mice.
    Shankar K; Kumar D; Gupta S; Varshney S; Rajan S; Srivastava A; Gupta A; Gupta AP; Vishwakarma AL; Gayen JR; Gaikwad AN
    Eur J Pharmacol; 2019 Jul; 854():354-364. PubMed ID: 30822393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
    Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T
    EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
    Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
    PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats.
    Valicherla GR; Gupta AP; Hossain Z; Riyazuddin M; Syed AA; Husain A; Lahiri S; Dave KM; Gayen JR
    Peptides; 2019 Oct; 120():170147. PubMed ID: 31473204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreastatin inhibitor PSTi8 ameliorates streptozotocin-induced diabetes by suppressing hepatic glucose production.
    Garg R; Katekar R; Parwez S; Agarwal A; Sahu S; Dadge S; Verma S; Goand UK; Siddiqi MI; Gayen JR
    Eur J Pharmacol; 2023 Apr; 944():175559. PubMed ID: 36764353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic acid reduces adipocyte hypertrophy and inflammation in diet-induced obese mice in an adiposity-independent manner.
    LeMieux MJ; Kalupahana NS; Scoggin S; Moustaid-Moussa N
    J Nutr; 2015 Mar; 145(3):411-7. PubMed ID: 25733455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice.
    Pires KM; Ilkun O; Valente M; Boudina S
    Obesity (Silver Spring); 2014 Jan; 22(1):178-87. PubMed ID: 23526686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
    Zhuge F; Ni Y; Nagashimada M; Nagata N; Xu L; Mukaida N; Kaneko S; Ota T
    Diabetes; 2016 Oct; 65(10):2966-79. PubMed ID: 27445264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreastatin inhibitor PSTi8 prevents free fatty acid-induced oxidative stress and insulin resistance by modulating JNK pathway: In vitro and in vivo findings.
    Garg R; Gupta AP; Katekar R; Verma S; Goand UK; Dadge S; Gayen JR
    Life Sci; 2022 Jan; 289():120221. PubMed ID: 34902437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice.
    Gupta AP; Singh P; Garg R; Valicherla GR; Riyazuddin M; Syed AA; Hossain Z; Gayen JR
    Biomed Pharmacother; 2019 Aug; 116():108959. PubMed ID: 31108350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.